Cytokine responses of TNF-α, IL-6, and IL-10 in G6PD-deficient infants

Pediatric Hematology and Oncology

Volumn 31, Issue 1, 2014, Pages 87-94

  Liao, Sui Ling ^a   Lai, Shen Hao ^a   Tsai, Ming Han ^a   Weng, Yi Hao ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Cytokine; G6PD deficiency; IL 10; IL 6; Infant; TNF

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; POLYINOSINIC POLYCYTIDYLIC ACID; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR AGONIST; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CONTROLLED STUDY; CYTOKINE RESPONSE; FEMALE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HUMAN; HUMAN CELL; INFANT; INFANT DISEASE; INFORMED CONSENT; MAJOR CLINICAL STUDY; MALE; NEWBORN PERIOD; PERIPHERAL BLOOD MONONUCLEAR CELL; PHOTOTHERAPY; PROTEIN EXPRESSION; STIMULATION;

CELLS, CULTURED; DISEASE SUSCEPTIBILITY; FOLLOW-UP STUDIES; GLUCOSEPHOSPHATE DEHYDROGENASE DEFICIENCY; HUMANS; HYPERBILIRUBINEMIA; INFANT; INFANT, NEWBORN; INTERLEUKIN-10; INTERLEUKIN-6; LEUKOCYTES, MONONUCLEAR; MALE; PHOTOTHERAPY; TOLL-LIKE RECEPTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84893332855     PISSN: 08880018     EISSN: 15210669     Source Type: Journal    
DOI: 10.3109/08880018.2013.865821     Document Type: Article

References (37)

1. HoHY, ChengML, Chiu DT.G6PD-an old bottlewith newwine. ChangGungMedJ. 2005;28:606-612.
2. Weng YH, Chou YH. Glucose-6-phosphate dehydrogenase deficiency with hyperbilirubinemia in neonates born inside and outside a tertiary hospital. Clin Neonat. 2003;10:50-53
3. Kaplan M, Hammerman C. Glucose-6-phosphate dehydrogenase deficiency: a hidden risk for kernicterus. Semin Perinatol. 2004;28:356-364.
4. Weng YH, Chiu YW. Spectrum and outcome analysis of marked neonatal hyperbilirubinemia with blood group incompatibility. Chang Gung Med J. 2009;32:400-408.
5. Weng YH, Chou YH, Lien RI.Hyperbilirubinemia in healthy neonates with glucose-6-phosphate dehydrogenase deficiency. Early Hum Dev. 2003;71:129-136.
6. Tang TK, Huang WY, Tang CJ, et al.Molecular basis of glucose-6-phosphate dehydrogenase (G6PD) deficiency in three Taiwan aboriginal tribes. Hum Genet. 1995;95:630-632.
7. Chiu DT, Zuo L, Chao L, et al. Molecular characterization of glucose-6-phosphate dehydrogenase (G6PD) deficiency in patients of Chinese descent and identification of new base substitutions in the human G6PD gene. Blood. 1993;81:2150-2154.
8. Abu-Osba YK, Mallouh AA, Hann RW. Incidence and causes of sepsis in glucose-6-phosphate dehydrogenase-deficient newborn infants. J Pediatr. 1989;114:748-752.
9. Chao YC, Huang CS, Lee CN, et al. Higher infection of dengue virus serotype 2 in human monocytes of patients with G6PD deficiency. PLoS One. 2008;3:e1557.
10. Costa E, Vasconcelos J, Santos E, et al. Neutrophil dysfunction in a case of glucose-6-phosphate dehydrogenase deficiency. J Pediatr Hematol Oncol. 2002;24:164-165.
11. Mamlok RJ,Mamlok V,Mills GC, et al. Glucose-6-phosphate dehydrogenase deficiency, neutrophil dysfunction and Chromobacterium violaceum sepsis. J Pediatr. 1987;111:852-854.
12. Gray GR, Stamatoyannopoulos G, Naiman SC, et al. Neutrophil dysfunction, chronic granulomatous disease, and non-spherocytic haemolytic anaemia caused by complete deficiency of glucose- 6-phosphate dehydrogenase. Lancet. 1973;2:530-534.
13. Spolarics Z, Siddiqi M, Siegel JH, et al. Increased incidence of sepsis and alteredmonocyte functions in severely injured type A- glucose-6-phosphate dehydrogenase-deficient African American trauma patients. Crit Care Med. 2001;29:728-736.
14. Vives Corrons JL, Feliu E, Pujades MA, et al. Severe-glucose-6-phosphate dehydrogenase (G6PD) deficiency associated with chronic hemolytic anemia, granulocyte dysfunction, and increased susceptibility to infections: description of a new molecular variant (G6PD Barcelona). Blood. 1982;59:428-434.
15. Tsai KJ, Hung IJ, Chow CK, et al. Impaired production of nitric oxide, superoxide, and hydrogen peroxide in glucose 6-phosphate-dehydrogenase-deficient granulocytes. FEBS Lett. 1998;436:411-414.
16. Upperman JS, Pillage G, Siddiqi MQ, et al. Dominance of high-producing interleukin 6 and lowproducing interleukin 10 and interferon gamma alleles in glucose-6-phosphate dehydrogenasedeficient trauma patients. Shock. 2005;23:197-201.
17. Liese AM, Siddiqi MQ, Siegel JH, et al. Attenuated monocyte IL-10 production in glucose-6- phosphate dehydrogenase-deficient trauma patients. Shock. 2002;18:18-23.
18. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell. 2006;124:783-801.
19. Hwang KC, Kuo MY, Lee PC. Erythrocyte G-6-PD activities of different age groups with reference to neonatal hyperbilirubinemia. Acta Paediatr Sinica. 1982;23:92-96.
20. Malik GB, Yadav R, Sehgal H. Immune response to pyogenic and non-pyogenic infection during infancy and childhood. Indian Pediatr. 1979;16:483-489.
21. Timens W, Boes A, Rozeboom-Uiterwijk T, Poppema S. Immaturity of the human splenic marginal zone in infancy. Possible contribution to the deficient infant immune response. J Immunol. 1989;143:3200-3206.
22. Kruschinski C, Zidan M, Debertin AS, et al. Age-dependent development of the splenic marginal zone in human infants is associated with different causes of death. Hum Pathol. 2004;35:113-121.
23. Levy O. Innate immunity of the human newborn: distinct cytokine responses to LPS and other Tolllike receptor agonists. J Endotoxin Res. 2005;11:113-116.
24. Caron JE, La Pine TR,Augustine NH, et al.Multiplex analysis of toll-like receptor-stimulated neonatal cytokine response. Neonatology. 2010;97:266-273.
25. Tatad AM,NesinM, Peoples J, et al. Cytokine expression in response to bacterial antigens in preterm and terminfant cord blood monocytes. Neonatology. 2008;94:8-15.
26. Beutler E, KuhlW, Vives-Corrons JL, Prchal JT.Molecular heterogeneity of glucose-6-phosphate dehydrogenase A. Blood. 1989;74:2550-2555.
27. Hartel C, Adam N, Strunk T, et al. Cytokine responses correlate differentially with age in infancy and early childhood. Clin Exp Immunol. 2005;142:446-453.
28. Sas AA, Jamshidi Y, Zheng D, et al.Theage-dependency of genetic and environmental influences on serumcytokine levels: a twin study. Cytokine. 2012;60:108-113.
29. Liao SL, Yeh KW, Lai SH, et al. Maturation of Toll-like receptor 1-4 responsiveness during early life. Early Hum Dev. 2013;89:473-478.
30. Bilmen S, Aksu TA, Gumuslu S, et al. Antioxidant capacity of G-6-PD-deficient erythrocytes. Clin Chim Acta. 2001;303:83-86.
31. Ondei LS, Silveira LM, Leite AA, et al. Lipid peroxidation and antioxidant capacity of G6PD-deficient patients with A-(202G>A)mutation. GenetMol Res. 2009;8:1345-1351.
32. Weng YH, Chou YH, Cheng ML, Chiu DTY. Increased heme oxygenase-1 expression in glucose-6- phosphate dehydrogenase deficient human fibroblasts. Pediatr Res. 2002;51:328A.
33. Ferreira A,Marguti I, Bechmann I, et al. Sickle hemoglobin confers tolerance to Plasmodium infection. Cell. 2011;145:398-409.
34. Soares MP, Bach FH. Heme oxygenase-1: from biology to therapeutic potential. Trends Mol Med. 2009;15:50-58.
35. Weng YH, Tatarov A, Bartos BP, et al. HO-1 expression in type II pneumocytes after transpulmonary gene delivery. Am J Physiol Lung Cell Mol Physiol. 2000;278:L1273-1279.
36. Weng YH, Yang G, Weiss S, Dennery PA. Interaction between heme oxygenase-1 and -2 proteins. J Biol Chem. 2003;278:50999-51005.
37. Weng YH, Chiu YW. Clinical characteristics of G6PD deficiency in infants with marked hyperbilirubinemia. J Pediatr Hematol Oncol. 2010;32:11-14.